bms 202 Search Results


bms 202  (MedChemExpress)
93
MedChemExpress bms 202
Bms 202, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms 202/product/MedChemExpress
Average 93 stars, based on 1 article reviews
bms 202 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
bms202  (TargetMol)
91
TargetMol bms202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms202, supplied by TargetMol, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms202/product/TargetMol
Average 91 stars, based on 1 article reviews
bms202 - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier
bms202  (MedChemExpress)
92
MedChemExpress bms202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms202, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms202/product/MedChemExpress
Average 92 stars, based on 1 article reviews
bms202 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
bms-202  (Bristol Myers)
90
Bristol Myers bms-202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms 202, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms-202/product/Bristol Myers
Average 90 stars, based on 1 article reviews
bms-202 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bms-202  (Aladdin Industrial Corporation)
90
Aladdin Industrial Corporation bms-202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms 202, supplied by Aladdin Industrial Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms-202/product/Aladdin Industrial Corporation
Average 90 stars, based on 1 article reviews
bms-202 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bms-202  (Ambeed Inc)
90
Ambeed Inc bms-202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms 202, supplied by Ambeed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms-202/product/Ambeed Inc
Average 90 stars, based on 1 article reviews
bms-202 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bms-202  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics bms-202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms 202, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms-202/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
bms-202 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bms-202  (PeproTech)
90
PeproTech bms-202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms 202, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms-202/product/PeproTech
Average 90 stars, based on 1 article reviews
bms-202 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bms-202  (Pharmatech)
90
Pharmatech bms-202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms 202, supplied by Pharmatech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms-202/product/Pharmatech
Average 90 stars, based on 1 article reviews
bms-202 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bms-202  (Curis Inc)
90
Curis Inc bms-202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms 202, supplied by Curis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms-202/product/Curis Inc
Average 90 stars, based on 1 article reviews
bms-202 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ce6/bms-202 nps  (Verlag GmbH)
90
Verlag GmbH ce6/bms-202 nps
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Ce6/Bms 202 Nps, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ce6/bms-202 nps/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
ce6/bms-202 nps - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bms-202  (ShangHai Biochempartner Co)
90
ShangHai Biochempartner Co bms-202
Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and <t>BMS202.</t> Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Bms 202, supplied by ShangHai Biochempartner Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bms-202/product/ShangHai Biochempartner Co
Average 90 stars, based on 1 article reviews
bms-202 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and BMS202. Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

Article Title: PD-L1 dimerisation induced by biphenyl derivatives mediates anti-breast cancer activity via the non-immune PD-L1–AKT–mTOR/Bcl2 pathway

doi: 10.1080/14756366.2023.2230388

Figure Lengend Snippet: Viability of MDA-MB-231 cells treated with 4 μM of compounds (A) 13h-1–3 , 13b-4–6 , 7b-2 , 7b-4 , and 12j-3–4 , and (B) MDA-MB-231, (C) A549, (D) HCC-827, (E) MCF-7, and (F) MRC-5 treated with compounds 12j-4 , 13h-1 , and 13h-3 with 0, 1, 2, 4, 8, 16, and 32 μM for 60 h, respectively. Cell viability was determined using the Cell Counting Kit-8 assay. Positive control: paclitaxel and BMS202. Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: BMS202 (CAS: 1675203–84-5) was purchased from TOPSCIENCE (Singapore).

Techniques: Cell Counting, Positive Control, Negative Control

Inhibition of the proliferation and migration of MDA-MB-231 cells with compound 12j-4. ( A ) The clone formation rates of MDA-MB-231 cells were treated with 12j-4 for 24 h at a concentration of 1 μM. ( B ) Migration ability of MDA-MB-231 cells treated with 12j-4 (1 μM) for 24 h and 48 h. Positive control: paclitaxel and BMS202. Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

Article Title: PD-L1 dimerisation induced by biphenyl derivatives mediates anti-breast cancer activity via the non-immune PD-L1–AKT–mTOR/Bcl2 pathway

doi: 10.1080/14756366.2023.2230388

Figure Lengend Snippet: Inhibition of the proliferation and migration of MDA-MB-231 cells with compound 12j-4. ( A ) The clone formation rates of MDA-MB-231 cells were treated with 12j-4 for 24 h at a concentration of 1 μM. ( B ) Migration ability of MDA-MB-231 cells treated with 12j-4 (1 μM) for 24 h and 48 h. Positive control: paclitaxel and BMS202. Negative control: 1% DMSO. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: BMS202 (CAS: 1675203–84-5) was purchased from TOPSCIENCE (Singapore).

Techniques: Inhibition, Migration, Concentration Assay, Positive Control, Negative Control

The expression level of PD-L1 is regulated by compound 12j-4. MDA-MB-231 cells were treated with 12j-4 for 48 h at a concentration of 1, 2, and 4 μM, respectively. BMS202 was used as a positive drug. ( A ) The expression of the PD-L1 protein and ( B ) PD-L1 mRNA was detected by Western blot and qPCR, respectively. The expression of PD-L1 protein was detected by ( C ) Western blot after MDA-MB-231 cells were treated with or without 12j-4 (4 μM) combined with GSK-3β inhibitor (40 nM) for 48 h. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Journal of Enzyme Inhibition and Medicinal Chemistry

Article Title: PD-L1 dimerisation induced by biphenyl derivatives mediates anti-breast cancer activity via the non-immune PD-L1–AKT–mTOR/Bcl2 pathway

doi: 10.1080/14756366.2023.2230388

Figure Lengend Snippet: The expression level of PD-L1 is regulated by compound 12j-4. MDA-MB-231 cells were treated with 12j-4 for 48 h at a concentration of 1, 2, and 4 μM, respectively. BMS202 was used as a positive drug. ( A ) The expression of the PD-L1 protein and ( B ) PD-L1 mRNA was detected by Western blot and qPCR, respectively. The expression of PD-L1 protein was detected by ( C ) Western blot after MDA-MB-231 cells were treated with or without 12j-4 (4 μM) combined with GSK-3β inhibitor (40 nM) for 48 h. Data are expressed as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: BMS202 (CAS: 1675203–84-5) was purchased from TOPSCIENCE (Singapore).

Techniques: Expressing, Concentration Assay, Western Blot